Yidan Chen
Hangzhou, 310002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Optimized patient-derived lung cancer organoids recapitulating the immune landscape for precision therapy evaluation.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: October 16, 2025
Patient-derived malignant effusion organoids guide tailored therapy and dissect third-generation EGFR-tyrosine kinase inhibitor resistance mechanisms in lung cancer.
Journal: Cancer letters
Published: September 07, 2025
Patient-derived organoid-guided precision therapy for a very young woman with multidrug-resistant metastatic breast cancer: a case report.
Journal: Frontiers in oncology
Published: May 18, 2025
Optimizing drug sensitivity assays in patient-derived tumor organoids: a comparison of IC50 estimation methods and experimental parameters.
Journal: Biology methods & protocols
Published: October 17, 2024
Anti-tumor effects of Cinnamomum camphora essential oil in breast cancer via NOX4 modulation by (+)-2-bornanone.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 11, 2024
Dual responsive drug-loaded nanomotor based on zwitterionic materials for the treatment of peritoneal metastatic cancer.
Journal: Journal of colloid and interface science
Published: July 30, 2024
Revisiting the role of pregnancy zone protein (PZP) as a cancer biomarker in the immunotherapy era.
Journal: Journal of translational medicine
Published: May 10, 2024
Nischarin inhibits the epithelial-mesenchymal transition process and angiogenesis in breast cancer cells by inactivating FAK/ERK signaling pathway via EGF like repeats and discoidin domains 3.
Journal: Molecular biology reports
Published: April 29, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026